Availability of drugs and resistance testing for bedaquiline, pretomanid, linezolid, and moxifloxacin (BPaL(M)) regimen for rifampicin-resistant tuberculosis in Europe: author's response.

Christoph LangeYousra KherabiLorenzo GuglielmettiRaquel DuarteGunar Günthernull null

Published in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases (2024)

Keyphrases

mycobacterium tuberculosis
pulmonary tuberculosis
drug resistant
multidrug resistant
methicillin resistant staphylococcus aureus
hiv aids
emergency department
adverse drug
human immunodeficiency virus
antiretroviral therapy